Epstein-Barr Virus Coinfection in COVID-19.
J Investig Med High Impact Case Rep
; 9: 23247096211040626, 2021.
Article
in English
| MEDLINE | ID: covidwho-1371944
ABSTRACT
Epstein-Barr virus (EBV), a member of the herpes virus family, is a causative agent for infectious mononucleosis in young adults. It has an asymptomatic and subclinical distribution in about 90% to 95% of the world population based on seropositivity. EBV is associated with various lymphomas, nasopharyngeal carcinoma, and in immunocompromised states can give rise to aggressive lymphoproliferative disorders. Symptomatic patients mostly present with mild hepatitis, rash, oral symptoms, lymphadenopathy, and generalized malaise. Recently with the COVID-19 (coronavirus disease-2019) pandemic, hepatitis has been found to be related to acute EBV and cytomegalovirus reactivation versus acute infection in the absence of other major causes. We describe a case of EBV coinfection in a patient with resolving mild COVID-19 infection.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Herpesvirus 4, Human
/
Epstein-Barr Virus Infections
/
Coinfection
/
SARS-CoV-2
/
COVID-19
Type of study:
Case report
Topics:
Long Covid
Limits:
Humans
/
Male
/
Middle aged
Language:
English
Journal:
J Investig Med High Impact Case Rep
Year:
2021
Document Type:
Article
Affiliation country:
23247096211040626
Similar
MEDLINE
...
LILACS
LIS